Celadon Pharmaceuticals PLC (CEL) — Tangible Net Worth Ratio
Celadon Pharmaceuticals PLC (CEL) has a Tangible Net Worth Ratio of 88.7% as of June 2024. This metric is calculated by deducting intangible assets (GBX278.00K) from net assets (GBX2.45 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Celadon Pharmaceuticals PLC short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Celadon Pharmaceuticals PLC Tangible Net Worth Ratio (2020–2023)
This chart shows how Celadon Pharmaceuticals PLC's Tangible Net Worth Ratio has changed across 4 annual periods from 2020 to 2023. As of June 2024, the ratio stands at 88.7%, reflecting net assets of GBX2.45 Million with intangible assets of GBX278.00K GBX. See Celadon Pharmaceuticals PLC defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Celadon Pharmaceuticals PLC (2020–2023)
The table below presents the year-by-year Tangible Net Worth Ratio for Celadon Pharmaceuticals PLC from 2020 to 2023, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see CEL market cap.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 92.2% | GBX3.18 Million | GBX248.00K | GBX9.22 Million | ▼ -2.9 pp |
| 2022 | 95.1% | GBX7.04 Million | GBX348.00K | GBX13.25 Million | ▲ +2.0 pp |
| 2021 | 93.0% | GBX6.41 Million | GBX448.00K | GBX6.61 Million | ▼ -7.0 pp |
| 2020 | 100.0% | GBX99.03K | GBX0.00 | GBX3.85 Million | — |